News Headlines

31. Avance Clinical Leads As The CRO Of Choice For Early Phase Clinical Trials In Australia – Announced At Biotech Showcase 2025 1/14/2025

    Wake Forest, NC, USA | Adelaide, Australia

    Avance Clinical, a leading full-service global Contract Research Organization (CRO) known for delivering high-quality, agile clinical research services, is proud to announce it is the CRO of choice for Early Phase clinical trials in Australia with more than 52% of market share. Avance Clinical Australia leads in the active Phase I trials, registered on clinical trial registry ANZCTR (as of 17 December 2024). More than 80% of Avance Clinical clients are US biotechs.

    Book a meeting with the Avance Clinical team at Biotech Showcase.

32. Novotech Releases Report On Global Parkinson's Disease Clinical Trial Landscape 12/30/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO), announces the release of its report, Parkinson’s Disease: Global Clinical Trial Landscape 2024. This report provides critical insights into the trends, opportunities, and challenges in Parkinson's disease (PD) research, serving as a valuable resource for companies developing treatments for this complex neurodegenerative disorder.

33. Novotech Named A Fierce CRO Award Winner In The Excellence In Clinical Trial Management And Global Operations Categories 12/30/2024

    Novotech has announced it was named a Fierce CRO Award winner by Fierce Biotech in the Clinical Trial Management and Global Operations categories.

34. Novotech Publishes Report On The Global COVID-19 Clinical Trial Landscape 12/30/2024

    The global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics, has released an in-depth report "COVID-19: Global Clinical Trial Landscape 2024."

35. OpenClinica Named Top Contender In Electronic Data Capture (EDC) Platforms By Everest Group 12/13/2024

    Everest Group, a leading global research and consulting firm, named OpenClinica a Major Contender in its Life Sciences Electronic Data Capture (EDC) Products PEAK Matrix^® Assessment for 2024. The inaugural assessment evaluated 20 best-in-class EDCs based on the impact created in the market and the ability to deliver products successfully. OpenClinica differentiates itself from other EDCs with its vision and capability, earning high marks in technology capability, flexibility and ease of deployment, engagement and commercial model, and customer support.

36. OpenClinica Debuts Secure, Participant-Friendly Mobile App For Direct Health Record Sharing In Clinical Research 12/13/2024

    OpenClinica Share™ simplifies the sharing of real-world and complex medical data for clinical research by participants.

37. Signant Health Names Krishna Maridi, A Finance Leader With Over 25 Years Of Experience, As Chief Financial Officer 12/11/2024

    Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Krishna Maridi as chief financial officer.

38. OpenClinica Acquires BuildClinical to Accelerate Patient Recruitment 12/10/2024

    OpenClinica today announced its acquisition of BuildClinical, a health technology company that helps researchers and patients find each other faster. BuildClinical uses advanced data-driven strategies to engage and enroll the ideal clinical trial population needed for a given study. Since its founding in 2020, BuildClinical has successfully enrolled more than 50,000 participants in clinical research studies, while simultaneously accelerating enrollment timelines and reducing participant engagement costs.

39. Novotech Publishes Comprehensive Report On The Global Vaccine Clinical Trials Landscape 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders.

40. Novotech Releases Report On Global Bladder Cancer Clinical Trials, Offering Insights For Oncology Advancement 12/4/2024

    Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors.